Press Releases August 4, 2026 09:00 AM

Haleon Canada Appoints Daniela Cavinatto as General Manager

Haleon appoints Daniela Cavinatto as General Manager for Canada to drive growth and strengthen market leadership

By Caleb Monroe
Share
Twitter Reddit Facebook LinkedIn
HLN

Haleon, a global consumer health company known for brands like Advil and Sensodyne, appointed Daniela Cavinatto as General Manager for Canada. With over 25 years of international leadership experience, Daniela aims to grow Haleon's Canadian business, enhance brand portfolios, and lead the company’s presence in this key market. Her previous leadership roles across multiple regions bring a global perspective and expertise in transformation and commercial growth, expected to strengthen Haleon's position in the consumer health sector in Canada.

Haleon Canada Appoints Daniela Cavinatto as General Manager
HLN
Summarize with
ChatGPT Perplexity Claude Grok Gemini

Key Points

  • Daniela Cavinatto has been appointed General Manager for Haleon Canada, bringing 25+ years of international leadership experience.
  • Haleon aims to strengthen its market leadership and grow its trusted brand portfolio including Advil, Sensodyne, and Centrum in Canada.
  • This leadership change underscores Haleon's commitment to the Canadian market, which impacts the consumer health and OTC pharmaceutical sectors.

MISSISSAUGA, Ontario, Aug. 04, 2026 (GLOBE NEWSWIRE) -- Haleon, a leading global consumer company, today announced the appointment of Daniela Cavinatto as General Manager, Canada. Daniela joins Haleon with more than 25 years of international leadership experience and a strong track record of driving business growth, leading transformation and building high-performing teams across complex consumer markets.

In her role, Daniela will lead Haleon's Canadian business as the company continues to strengthen its market leadership, grow its portfolio of trusted brands which include Advil, Sensodyne, Centrum and more, and advance its purpose of delivering better everyday health with humanity.

"Daniela is an accomplished business leader with a proven ability to unlock growth, navigate complexity and deliver results in dynamic markets," said Nathalie Gerschtein, President, North America, Haleon. "Canada is an important growth market for Haleon, and Daniela brings the commercial acumen, global perspective and leadership experience needed to help us build on our momentum. I am delighted to welcome Daniela to our North American Leadership Team and look forward to working with her as we strengthen our trusted brand portfolio and advance our leadership in consumer health."

Prior to joining Haleon, Daniela served as General Manager, Canada for The LEGO Group, where she led a successful business by redefining market strategy, strengthening customer partnerships and optimizing commercial investments. Throughout her career, she has held senior leadership roles across North America, Latin America and Europe, with experience spanning general management, sales, marketing, customer development, eCommerce, retail operations and supply chain.

Known for leading through transformation and developing strong teams, Daniela brings a combination of commercial acumen, operational discipline and global perspective that will help advance Haleon's ambitions in Canada.

"Throughout my career, I've been inspired by opportunities to transform businesses, accelerate growth and help teams achieve ambitious goals," said Daniela Cavinatto, General Manager, Haleon Canada. "That's what makes this opportunity so compelling. Haleon's portfolio of brands is rooted in science and consumer understanding with six in 10 Canadian households relying on at least one of our iconic brands. To lead a business with this kind of reach and impact is a true privilege and an opportunity that deeply inspires me. I am energized by the road ahead and excited to work alongside our talented team, customers and partners as we continue to grow, innovate and build on Haleon's strong momentum in Canada."

About Haleon 
Haleon (LSE / NYSE: HLN) is a globally leading consumer company that is solely focused on better everyday health. Haleon's product portfolio spans three major categories: Oral Health, Over-the-Counter (OTC), and Wellness. Its long-standing brands including Advil, Buckley’s, Centrum, Emergen-C, Sensodyne, TUMS, Voltaren and more, are built on trusted science, innovation and deep human understanding. For more information on Haleon and its brands visit Haleon Canada or contact [email protected].

Aaron Short Media InquiriesNvoy [email protected]@haleon.com  

A photo accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/35165291-2590-4c2d-98d6-0146a8378793


Risks

  • Potential challenges in navigating competitive and evolving consumer health markets in Canada could impact growth.
  • Execution risks related to transforming and optimizing commercial strategies in a complex market environment.
  • Uncertainties around consumer behavior and regulatory changes in the OTC and wellness sectors potentially affecting product performance.

More from Press Releases

Q/C Technologies Appoints Veteran Silicon Photonics Engineer Yossef Ehrlichman as Founding Manager, Photonic Integrated Circuit (PIC) Development Aug 4, 2026 Silexion Therapeutics Reports New Positive Preclinical Findings Demonstrating Multi-Mechanism Immune Sensitization by SIL204 in KRAS-Driven Cancers Aug 4, 2026 Immix Biopharma to Participate in the Morgan Stanley 24th Annual Global Healthcare Conference Aug 4, 2026 BOS Secures $1.9 Million in Purchase Orders for an Air Defense Project Aug 4, 2026 Tenable Advances Exposure Management with Coverage Across Every Major AI Platform and Developer Tool Aug 4, 2026